资讯

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...
Kalaris Therapeutics initiates a phase 1b/2 study for TH103, targeting neovascular age-related macular degeneration and ...
Lions World Vision Institute enhances corneal surgery with asymmetrical laser-cut CAIRS, offering tailored solutions for ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
On September 26 and 27, 2025, the Ophthalmology Times and Optometry Times EyeCon 2025 conference will convene at the ...
K8 was found to reduce geographic atrophy lesion area growth by more than 50% in its first human clinical trial of the drug.